Variable agreement among experts regarding Mycobacterium avium complex lung disease

Respirology

Volumn 20, Issue 2, 2015, Pages 348-351

  Marras, Theodore K ^a,b   Prevots, D Rebecca ^b   Jamieson, Frances B ^c,d   Winthrop, Kevin L ^e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Delphi technique; Mycobacterium avium intracellulare infection; mycobacterium infection; non tuberculous mycobacterium; practice guideline

Indexed keywords

ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM ISOLATION; CLINICAL FEATURE; DELPHI STUDY; DISEASE COURSE; HUMAN; LUNG DISEASE; MYCOBACTERIUM AVIUM COMPLEX; NONHUMAN; NORTH AMERICAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SURVIVAL; ATTITUDE TO HEALTH; COMPLICATION; EXPERT WITNESS; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NORTH AMERICA;

DELPHI TECHNIQUE; EXPERT TESTIMONY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG DISEASES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NORTH AMERICA; PRACTICE GUIDELINES AS TOPIC;

EID: 84921507854     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12440     Document Type: Article

References (15)

1. AlHouqani M, Jamieson F, Mehta M, Chedore P, May K, Marras TK,. Aging COPD and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 2012; 141: 190-197.
2. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K,. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am. J. Respir. Crit. Care Med. 2010; 182: 977-982.
3. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am. J. Respir. Crit. Care Med. 2010; 182: 970-976.
4. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB,. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg. Infect. Dis. 2013; 19: 1889-1891.
5. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR,. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am. J. Respir. Crit. Care Med. 2012; 185: 881-886.
6. AlHouqani M, Jamieson F, Chedore P, Mehta M, May K, Marras TK,. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario 2007. Can. Respir. J. 2011; 18: 19-24.
7. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007; 175: 367-416.
8. Huang JH, Kao PN, Adi V, Ruoss SJ,. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999; 115: 1033-1040.
9. Field SK, Fisher D, Cowie RL,. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004; 126: 566-581.
10. Leber A, Marras TK,. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. Eur. Respir. J. 2011; 37: 1158-1165.
11. Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR,. Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir. Med. 2009; 103: 1448-1455.
12. Collier SA, Stockman LJ, Hicks LA, Garrison LE, Zhou FZ, Beach MJ,. Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiol. Infect. 2012; 140: 2003-2013.
13. Jones J, Hunter D,. Consensus methods for medical and health services research. BMJ 1995; 311: 376-380.
14. Wenger DR,. Limitations of evidence-based medicine: the role of experience and expert opinion. J. Pediatr. Orthop. 2012; 32 (Suppl. 2): S187-192.
15. Sackett DL, Haynes RB,. Evidence-based medicine: editors' reply. BMJ 1996; 312: 380.